Group One Trading, L.P. Acer Therapeutics Inc. Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$0.57 - $1.28 $1,802 - $4,047	3,162 New	3,162 $2,000
Q4 2022 Feb 09, 2023	SELL	$1.13 - $4.15 $8,351 - $30,672	-7,391 Reduced 91.57%	680 $1,000
Q3 2022 Nov 09, 2022	BUY	$1.28 - $1.6 $8,064 - $10,080	6,300 Added 355.73%	8,071 $11,000
Q2 2022 Aug 11, 2022	BUY	$1.19 - $3.04 $2,107 - $5,383	1,771 New	1,771 $2,000
Q4 2021 Feb 11, 2022	SELL	$1.88 - $2.9 $3,572 - $5,510	-1,900 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.3 - $2.86 $459 - $572	200 Added 11.76%	1,900 $5,000
Q2 2021 Aug 10, 2021	SELL	$2.52 - $3.18 $1,764 - $2,226	-700 Reduced 29.17%	1,700 $5,000
Q1 2021 May 12, 2021	BUY	$2.47 - $4.39 $5,928 - $10,536	2,400 New	2,400 $7,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.